LDX lumos diagnostics holdings limited

Ann: Q2 FY25 Results Investor Briefing Invitation, page-38

  1. 1,070 Posts.
    lightbulb Created with Sketch. 231
    That really shows an underlying value in the company's IP/assets, and the fact the company values their future prospects much higher than the current market cap, especially when looking at the money and time spent on getting FDA approval in the first place for FebriDx. Something which isn't really reflected in the current share price.
    Last edited by Istina: 07/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.5¢
Change
0.004(4.40%)
Mkt cap ! $71.10M
Open High Low Value Volume
9.4¢ 9.8¢ 9.1¢ $1.025M 10.78M

Buyers (Bids)

No. Vol. Price($)
1 100000 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 25928 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
LDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.